Global hotspots and future prospects of chimeric antigen receptor T-cell therapy in cancer research: a bibliometric analysis.

James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman, Wyndham H. Wilson, David E. Spaner, Irina Maric, Maryalice Stetler-Stevenson, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, James C. Yang, Udai S. Kammula, Laura Devillier, Robert Carpenter, Debbie-Ann N. Nathan, Richard A. Morgan, Carolyn Laurencot, Steven A. Rosenberg, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells Blood. ,vol. 119, pp. 2709- 2720 ,(2012) , 10.1182/BLOOD-2011-10-384388

Christian Blank, Andreas Mackensen, Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunology, Immunotherapy. ,vol. 56, pp. 739- 745 ,(2007) , 10.1007/S00262-006-0272-1

G. Gross, T. Waks, Z. Eshhar, Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 10024- 10028 ,(1989) , 10.1073/PNAS.86.24.10024

Martin A Pule, Barbara Savoldo, G Doug Myers, Claudia Rossig, Heidi V Russell, Gianpietro Dotti, M Helen Huls, Enli Liu, Adrian P Gee, Zhuyong Mei, Eric Yvon, Heidi L Weiss, Hao Liu, Cliona M Rooney, Helen E Heslop, Malcolm K Brenner, None, Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma Nature Medicine. ,vol. 14, pp. 1264- 1270 ,(2008) , 10.1038/NM.1882

Richard A Morgan, James C Yang, Mio Kitano, Mark E Dudley, Carolyn M Laurencot, Steven A Rosenberg, Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 Molecular Therapy. ,vol. 18, pp. 843- 851 ,(2010) , 10.1038/MT.2010.24

Stephan A. Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey, Anne Chew, Bernd Hauck, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, Carl H. June, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. The New England Journal of Medicine. ,vol. 368, pp. 1509- 1518 ,(2013) , 10.1056/NEJMOA1215134

Sonia Roman, Alcoholism and liver disease in Mexico: Genetic and environmental factors World Journal of Gastroenterology. ,vol. 19, pp. 7972- 7982 ,(2013) , 10.3748/WJG.V19.I44.7972

Matthew E. Falagas, Eleni I. Pitsouni, George A. Malietzis, Georgios Pappas, Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses The FASEB Journal. ,vol. 22, pp. 338- 342 ,(2007) , 10.1096/FJ.07-9492LSF

Danny R Youlden, Susanna M Cramb, Nathan AM Dunn, Jennifer M Muller, Christopher M Pyke, Peter D Baade, None, The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality Cancer Epidemiology. ,vol. 36, pp. 237- 248 ,(2012) , 10.1016/J.CANEP.2012.02.007

David L. Porter, Bruce L. Levine, Michael Kalos, Adam Bagg, Carl H. June, Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia The New England Journal of Medicine. ,vol. 365, pp. 725- 733 ,(2011) , 10.1056/NEJMOA1103849